Karnataka FDA exposes illegal profiteering by 254 pharmaceutical companies
Headline by Prism · from 1 report
The Karnataka Food and Drug Administration has identified 254 pharmaceutical companies allegedly inflating the prices of medicines and medical devices by 60 to 90 times.
TV9 KannadaThe brief
Written by software from the 1 report below.
- The Karnataka Food and Drug Administration has identified 254 pharmaceutical companies for charging exorbitant prices for medicines and medical equipment.
- These companies were reportedly marking up prices by 60 to 90 times the procurement cost.
- The state commissioner has written to the National Pharmaceutical Pricing Authority requesting urgent intervention to regulate these costs.
- This action aims to stop the exploitation of patients by curbing excessive trade margins on essential medical supplies.
What to watch next
- Decision by the National Pharmaceutical Pricing Authority on regulating these price markups
- Potential state or federal legal action against the identified companies
The points restate the reports; where one says why it matters, that is Prism's reading, not a reported fact.
Coverage
1 outlet
All filed from India
NamedIndia · Karnataka Food and Drug Administration · K. Srinivas · National Pharmaceutical Pricing Authority
The 1 report is listed beside the record.
Corrections and versions
A correction says what was wrong and why. Every earlier headline and brief of this record is kept.
Something wrong?
Say what, and it arrives with this record's address filled in. A correction is welcome.
Ask this story
Answers cite the 1 report above, or say they can't.